GSK's Votrient gets conditional OK in Europe for renal cancer - Pharma Times PDF Print
Pharma TimesThe European Commission has granted a conditional marketing authorisation for Votrient (pazopanib) for the first-line treatment of advanced renal cell

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.